Perpetua Denica Shillingford, PhD, MBA, is an accomplished research scientist specializing in formulation and process development at Gilead Sciences. Prior to this role, Perpetua worked as a health safety analyst at QuidelOrtho, a subsidiary of Ortho Clinical Diagnostics, and gained experience as a graduate research and teaching assistant at Nova Southeastern University. Additionally, Perpetua served as the assistant director of admissions at EDMC and as an admissions representative at Fortis College-Columbus. Perpetua holds a Doctor of Philosophy in Drug Development (Pharmaceutics) from Nova Southeastern University and a Master of Business Administration from the University of Tampa - John H. Sykes College of Business.
Previous companies
November, 2022 - present